株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ヒアルロン酸の世界市場 - 市場規模、シェア、動向分析:用途(皮膚充填剤、変形性関節症、眼科、膀胱尿管逆流症)別 2019年~2026年

Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), By Region (North America, APAC, Europe, MEA), And Segment Forecasts, 2019 - 2026

発行 Grand View Research, Inc. 商品コード 370474
出版日 ページ情報 英文 100 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.69円で換算しております。
Back to Top
ヒアルロン酸の世界市場 - 市場規模、シェア、動向分析:用途(皮膚充填剤、変形性関節症、眼科、膀胱尿管逆流症)別 2019年~2026年 Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), By Region (North America, APAC, Europe, MEA), And Segment Forecasts, 2019 - 2026
出版日: 2019年05月28日 ページ情報: 英文 100 Pages
概要

世界のヒアルロン酸市場は、2019年から2026年にかけて7.8%のCAGRで推移し、2026年までに152億5,000万米ドル規模の市場に成長すると予測されています。有毒化学物質に対する懸念の高まり、ダウンタイムの短さ、世界的な美容整形手術の増加などによって当市場の成長が促進されています。

当レポートでは、世界のヒアルロン酸市場を調査し、市場の概要、用途・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査方法と範囲

  • 市場区分と範囲
  • 調査方法
  • 情報調達
  • データ分析
  • 市場の定式化と検証
  • モデル詳細
  • 二次出典リスト
  • 一次出典リスト
  • 略語リスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場の見通し
  • 市場の見通し:セグメント別
  • 市場の見通し

第3章 市場変数、動向、範囲

  • 市場の見通し
  • 市場セグメンテーション
  • 普及と成長見通しのマッピング
  • 市場分析ツール

第4章 ヒアルロン酸市場の予測と動向分析:用途別

  • 市場動向の分析:用途別
  • 皮膚充填剤
  • 変形性関節症
    • 単回投与
    • 3回投与
    • 5回投与
  • 眼科
  • 膀胱尿管逆流

第5章 ヒアルロン酸市場の予測と動向分析:地域別

  • 市場シェア:地域別(実績値・予測値)
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • インド
    • 中国
    • 日本
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東・アフリカ地域
    • 南アフリカ

第6章 償還シナリオ

  • 償還シナリオ:製品別
  • 償還シナリオ:地域別

第7章 競合情勢

  • 近年の開発動向と影響分析:参入企業別
  • 戦略の枠組み
  • ベンダー情勢
  • 企業ポジショニング分析
  • 企業プロファイル
    • Allergan
    • Sanofi
    • Genzyme Corporation
    • Anika Therapeutics, Inc.
    • Salix Pharmaceuticals, Inc.
    • 生化学工業
    • Galderma S.A
    • Zimmer Biomet
    • Smith & Nephew Plc
    • Ferring B.V.
    • Lifecore Biomedical, LLC
    • HTL Biotechnology
    • 資生堂
    • Bloomage Freda Biopharm Co. Ltd.
    • LG Life Sciences Ltd
    • マルハニチロ
    • Fluidigm Corporation

第8章 提言

図表

List of Tables

  • TABLE 1 Primary interview details: North America
  • TABLE 2 Primary interview details: Europe
  • TABLE 3 Primary interview details: APAC
  • TABLE 4 Primary interview details: Latin America
  • TABLE 5 Primary interview details: MEA
  • TABLE 6 List of secondary sources
  • TABLE 7 List of abbreviation
  • TABLE 8 Joint ventures, mergers and acquisition
  • TABLE 9 Licensing & partnerships, technology collaborations
  • TABLE 10 North America hyaluronic acid market estimates and forecasts, by country, 2015 - 2026 (USD Million)
  • TABLE 11 North America Hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 12 U.S. hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 13 Canada hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 14 Europe hyaluronic acid market estimates and forecasts, by country, 2015 - 2026 (USD Million)
  • TABLE 15 Europe hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 16 U.K. hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 17 Germany hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 18 France hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 19 Italy hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 20 Spain hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 21 Asia Pacific hyaluronic acid market estimates and forecasts, by country, 2015 - 2026 (USD Million)
  • TABLE 22 Asia Pacific hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 23 India hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 24 China hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 25 Japan hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 26 Latin America hyaluronic acid market estimates and forecasts, by country, 2015 - 2026 (USD Million)
  • TABLE 27 Latin America hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 28 Brazil hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 29 Mexico hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 30 MEA hyaluronic acid market estimates and forecasts, by country, 2015 - 2026 (USD Million)
  • TABLE 31 MEA hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)
  • TABLE 32 South Africa hyaluronic acid market estimates and forecasts, by application, 2015 - 2026 (USD Million)

List of Figures

  • FIG. 1 Market outlook
  • FIG. 2 Market trends & scope
  • FIG. 3 Market segmentation
  • FIG. 4 Market driver relevance analysis (Current & future impact)
  • FIG. 5 Market restraint relevance analysis (Current & future impact)
  • FIG. 6 Penetration & growth prospect mapping
  • FIG. 7 PEST - SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 8 Porter's Five Forces Analysis
  • FIG. 9 Hyaluronic Acid market application outlook key takeaways
  • FIG. 10 Hyaluronic Acid market: application movement analysis
  • FIG. 11 Global dermal fillers market, 2015 - 2026 (USD Million)
  • FIG. 12 Global osteoarthritis market, 2015 - 2026 (USD Million)
  • FIG. 13 Global single injection market, 2015 - 2026 (USD Million)
  • FIG. 14 Global three injection market, 2015 - 2026 (USD Million)
  • FIG. 15 Global five injection market, 2015 - 2026 (USD Million)
  • FIG. 16 Global ophthalmic market, 2015 - 2026 (USD Million)
  • FIG. 17 Global vesicoureteral reflux market, 2015 - 2026 (USD Million)
  • FIG. 18 Regional market place: Key takeaways
  • FIG. 19 Regional outlook, 2018 & 2026
  • FIG. 20 North America hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 21 U.S. hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 22 Canada hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 23 Europe hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 24 U.K. hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 25 Germany hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 26 France hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 27 Italy hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 28 Spain hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 29 Asia Pacific hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 30 India hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 31 China hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 32 Japan hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 33 Latin America hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 34 Brazil hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 35 Mexico hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 36 MEA hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 37 South Africa hyaluronic acid market, 2015 - 2026 (USD Million)
  • FIG. 38 Recent development & impact analysis by key market participants
  • FIG. 39 Strategy framework
  • FIG. 40 Strategy mapping
目次
Product Code: 978-1-68038-333-1

The global hyaluronic acid market size is expected to reach USD 15.25 billion by 2026 registering a CAGR of 7.8%, according to a new report by Grand View Research, Inc. Factors, such as increasing concern about toxic chemicals, need for quick and evident results, and shorter recovery time are high impact rendering drivers of this market. The market is witnessing rapid growth due to increasing adoption of aesthetic procedures across the globe.

Wide usage of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving the compatibility coupled with growing awareness about anti-aging products is driving the market. In addition, increasing cases of obesity indicate a rising number of people suffering from orthopedic disorders, which do not have any permanent cure and the treatments include pain-killers. However, hyaluronic acid-based viscosupplements are expected to be a possible cure for joint pain. Orthovisc, approved in 2013, and Monovisc, approved in 2016, by Anika Therapeutics, Inc. are among the popular viscosupplements.

Increasing popularity of cosmetic surgeries across the globe is also expected to boost the market growth. In 2013, hyaluronan-based facial fillers received FDA approval, which is used in corrective measures, anti-aging procedure, and filling fine lines. North America led the market in 2018. Presence of key companies, such as Genzyme Corporation and Anika Therapeutics, in this region contributes to market growth. Increasing number of anti-aging procedures performed and resultant demand for dermal fillers are expected to drive the regional market further.

Further key findings from the study suggest:

Rising cases of obesity resulting in increased number of cases of osteoarthritis and joint pain has boosted the demand for hyaluronic acid injections as treatment

According to the studies, the number of people suffering from osteoarthritis is expected to grow from 53 million in 2012 to 78 million by 2040

Asia Pacific is anticipated to emerge as the fastest-growing regional market during the forecast period due to growing geriatric population in China and Japan, which provides a large customer base for anti-aging products and services

Some of the key companies in the global hyaluronic acid market are F. Hoffmann-La Roche Ltd.; Seikagaku Corp.; Galderma S.A.; Sanofi (Genzyme); Anika Therapeutics, Inc.; Salix Pharmaceuticals; Zimmer Holdings, Inc.; Allergan, Inc.; Ferring Pharmaceuticals, Inc.; and Smith & Nephew Plc

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Application
    • 1.1.2 Regional
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.2 Data for primary interviews in Europe
      • 1.3.5.3 Data for primary interviews in Asia Pacific
      • 1.3.5.4 Data for primary interviews in Latin America
      • 1.3.5.5 Data for primary interviews in MEA
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Application
    • 2.2.2 Region
    • 2.2.3 Competitive Insights
  • 2.3 Market Outlook

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Market segmentation
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
  • 3.3 Penetration & growth prospect mapping
  • 3.4 Hyaluronic Acid Market Analysis Tools
    • 3.4.1 PEST - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
    • 3.4.2 Industry Analysis - Porter's
    • 3.4.3 Major Delas And Strategic Analysis
      • 3.4.3.1 Joint ventures, mergers and acquisition
      • 3.4.3.2 Licensing & partnerships, technology collaborations

Chapter 4 Hyaluronic Acid Market: Application Estimates & Trend Analysis

  • 4.1 Hyaluronic Acid market: Application Movement Analysis
  • 4.2 Dermal Fillers
    • 4.2.1 Dermal Fillers Market, 2015 - 2026 (USD Million)
  • 4.3 Osteoarthritis
    • 4.3.1 Osteoarthritis Market, 2015 - 2026 (USD Million)
    • 4.3.2 Single Injection
      • 4.3.2.1 Single injection market, 2015 - 2026 (USD Million)
    • 4.3.3 Three Injection
      • 4.3.3.1 Three injection market, 2015 - 2026 (USD Million)
    • 4.3.4 Five Injection
      • 4.3.4.1 Five injection market, 2015 - 2026 (USD Million)
  • 4.4 Ophthalmic
    • 4.4.1 Ophthalmic Market, 2015 - 2026 (USD Million)
  • 4.5 Vesicoureteral reflux
    • 4.5.1 Vesicoureteral reflux Market, 2015 - 2026 (USD Million)

Chapter 5 Hyaluronic Acid Market: Regional Estimates & Trend Analysis

  • 5.1 Hyaluronic Acid Market Share, by Region, 2018 & 2026
  • 5.2 North America
    • 5.2.1 North America Hyaluronic Acid Market, 2015 - 2026 (USD Million)
    • 5.2.2 U.S
      • 5.2.2.1 U.S hyaluronic acid market, 2015 - 2026 (USD Million)
    • 5.2.3 Canada
      • 5.2.3.1 Canada hyaluronic acid market, 2015 - 2026 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Hyaluronic Acid Market, 2015 - 2026 (USD Million)
    • 5.3.2 U.K.
      • 5.3.2.1 U.K. hyaluronic acid market, 2015 - 2026 (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Germany hyaluronic acid market, 2015 - 2026 (USD Million)
    • 5.3.4 France
      • 5.3.4.1 France hyaluronic acid market, 2015 - 2026 (USD Million)
    • 5.3.5 Italy
      • 5.3.5.1 Italy hyaluronic acid market, 2015 - 2026 (USD Million)
    • 5.3.6 Spain
      • 5.3.6.1 Spain hyaluronic acid market, 2015 - 2026 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Hyaluronic Acid Market, 2015 - 2026 (USD Million)
    • 5.4.2 India
      • 5.4.2.1 India hyaluronic acid market, 2015 - 2026 (USD Million)
    • 5.4.3 China
      • 5.4.3.1 China hyaluronic acid market, 2015 - 2026 (USD Million)
    • 5.4.4 Japan
      • 5.4.4.1 Japan hyaluronic acid market, 2015 - 2026 (USD Million)
  • 5.5 Latin America
    • 5.5.1 Latin America Hyaluronic Acid Market, 2015 - 2026 (USD Million)
    • 5.5.2 Brazil
      • 5.5.2.1 Brazil hyaluronic acid market, 2015 - 2026 (USD Million)
    • 5.5.3 Mexico
      • 5.5.3.1 Mexico hyaluronic acid market, 2015 - 2026 (USD Million)
  • 5.6 MEA
    • 5.5.1 MEA Hyaluronic Acid Market, 2015 - 2026 (USD Million)
    • 5.5.2 South Africa
      • 5.5.2.1 South Africa hyaluronic acid market, 2015 - 2026 (USD Million)

Chapter 6 Reimbursement Scenario

  • 6.1 Reimbursement by Product
    • 6.1.1 Gel-one
    • 6.1.2 EUFLEXXA
    • 6.1.3 Synvisc-One
    • 6.1.4 Supartz
    • 6.1.5 Hyalgan
    • 6.1.6 Monovisc
    • 6.1.7 Orthovisc
    • 6.1.8 Juvederm, Emervel, Restylane, Macrolane, Belotero, Filorga, Jalupro, Princess, Teosyal, Stylage, Filorga and others
  • 6.2 Reimbursement by Region
    • 6.2.1 U.S.
    • 6.2.2 Canada
    • 6.2.3 China
    • 6.2.4 Japan
    • 6.2.5 India
    • 6.2.6 Brazil
    • 6.2.7 South Africa
    • 6.2.8 Europe

Chapter 7 Competitive Landscape

  • 7.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 7.2 Strategy Framework
  • 7.3 Vendor Landscape
    • 7.3.1 List Of Key Distributors And Channel Partners
    • 7.3.2 Strategy Mapping
      • 7.3.2.1 Partnerships
      • 7.3.2.2 Launch of new product
      • 7.3.2.3 Merger & acquisition
      • 7.3.2.4 Geographical expansion
      • 7.3.2.5 Marketing & promotions
  • 7.4 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
  • 7.5 Company Profiles
    • 7.5.1 Allergan
      • 7.5.1.1 Company overview
      • 7.5.1.2 Financial performance
      • 7.5.1.3 Product benchmarking
      • 7.5.1.4 Strategic initiatives
      • 7.5.1.5 SWOT analysis
    • 7.5.2 Sanofi
      • 7.5.2.1 Company overview
      • 7.5.2.2 Financial performance
      • 7.5.2.3 Product benchmarking
      • 7.5.2.4 Strategic initiatives
      • 7.5.2.5 SWOT analysis
    • 7.5.3 Genzyme Corporation
      • 7.5.3.1 Company overview
      • 7.5.3.2 Financial performance
      • 7.5.3.3 Product benchmarking
      • 7.5.3.4 Strategic initiatives
      • 7.5.3.5 SWOT analysis
    • 7.5.4 Anika Therapeutics, Inc.
      • 7.5.4.1 Company overview
      • 7.5.4.2 Financial performance
      • 7.5.4.3 Product benchmarking
      • 7.5.4.4 Strategic initiatives
      • 7.5.4.5 SWOT analysis
    • 7.5.5 Salix Pharmaceuticals, Inc.
      • 7.5.5.1 Company overview
      • 7.5.5.2 Financial performance
      • 7.5.5.3 Product benchmarking
      • 7.5.5.4 Strategic initiatives
      • 7.5.5.5 SWOT analysis
    • 7.5.6 Seikagaku Corporation
      • 7.5.6.1 Company overview
      • 7.5.6.2 Financial performance
      • 7.5.6.3 Product benchmarking
      • 7.5.6.4 Strategic initiatives
      • 7.5.6.5 SWOT analysis
    • 7.5.7 F. Hoffmann-La Roche AG
      • 7.5.7.1 Company overview
      • 7.5.7.2 Financial performance
      • 7.5.7.3 Product benchmarking
    • 7.5.8 Galderma S.A.
      • 7.5.8.1 Company overview
      • 7.5.8.2 Financial performance
      • 7.5.8.3 Product benchmarking
      • 7.5.8.4 Strategic initiatives
      • 7.5.8.5 SWOT analysis
    • 7.5.9 Zimmer Biomet
      • 7.5.9.1 Company overview
      • 7.5.9.2 Financial performance
      • 7.5.9.3 Product benchmarking
      • 7.5.9.4 Strategic initiatives
      • 7.5.9.5 SWOT analysis
    • 7.5.10 Smith & Nephew Plc
      • 7.5.10.1 Company overview
      • 7.5.10.2 Financial performance
      • 7.5.10.3 Product benchmarking
      • 7.5.10.4 Strategic initiatives
      • 7.5.10.5 SWOT analysis
    • 7.5.11 Ferring B.V.
      • 7.5.11.1 Company overview
      • 7.5.11.2 Product benchmarking
      • 7.5.11.3 Strategic initiatives
    • 7.5.12 Lifecore Biomedical, LLC
      • 7.5.12.1 Company overview
      • 7.5.12.2 Financial performance
      • 7.5.12.3 Product benchmarking
      • 7.5.12.4 Strategic initiatives
      • 7.5.12.5 SWOT analysis
    • 7.5.13 HTL Biotechnology
      • 7.5.13.1 Company overview
      • 7.5.13.2 Product benchmarking
    • 7.5.14 Shiseido
      • 7.5.14.1 Company overview
      • 7.5.14.2 Financial performance
      • 7.5.14.3 Product benchmarking
      • 7.5.14.4 Strategic initiatives
      • 7.5.14.5 SWOT analysis
    • 7.5.15 Bloomage Freda Biopharm Co. Ltd.
      • 7.5.15.1 Company overview
      • 7.5.15.2 Product benchmarking
      • 7.5.15.3 Strategic initiatives
    • 7.5.16 LG Life Sciences Ltd
      • 7.5.16.1 Company overview
      • 7.5.16.2 Product benchmarking
      • 7.5.16.3 Strategic initiatives
    • 7.5.17 Maruha Nichiro, Inc.
      • 7.5.17.1 Company overview
      • 7.5.17.2 Financial performance
      • 7.5.17.3 Product benchmarking
      • 7.5.17.4 Strategic initiatives
      • 7.5.17.5 SWOT analysis
    • 7.5.18 Fluidigm Corporation
      • 7.5.18.1 Company overview
      • 7.5.18.2 Financial performance
      • 7.5.18.3 Product benchmarking
      • 7.5.18.4 Strategic initiatives
      • 7.5.18.5 SWOT analysis

Chapter 8 Recommendations

Back to Top